Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma.

Cancer - 15 Apr 2012

Niemeier Leo A, Kuffner Akatsu Haruko, Song Chi, Carty Sally E, Hodak Steven P, Yip Linwah, Ferris Robert L, Tseng George C, Seethala Raja R, Lebeau Shane O, Stang Michael T, Coyne Christopher, Johnson Jonas T, Stewart Andrew F, Nikiforov Yuri E

Abstract excerpt

BACKGROUND: Thyroid papillary microcarcinoma (TPMC) is an incidentally discovered papillary carcinoma that measures ≤1.0 cm in size. Most TPMCs are indolent, whereas some behave aggressively. The objective of the study was to evaluate whether the combination of v-raf murine sarcoma viral oncogene homolog B1 (BRAF) mutation and specific histopathologic features allows risk stratification of TPMC. METHODS: A group...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to Carcinoma, Papillary

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Lymphatic Metastasis

Share to Proto-Oncogene Proteins B-raf

Share to Recurrence

Share to Risk Assessment

Share to Thyroid Cancer, Papillary

Share to Thyroid Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 21882177
DOI: 10.1002/cncr.26425
PMCID: PMC3229649

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma.PMID 21882177Read ↗

Association of BRAFV600E Mutation with the Aggressive Behavior of Papillary Thyroid Microcarcinoma: A Meta-Analysis of 33 Studies.Semantic proximity Read ↗

Risk factors associated with aggressive tumor phenotypes in papillary thyroid microcarcinoma: a systematic review and meta-analysis.Semantic proximity Read ↗

The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma.Semantic proximity Read ↗

BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis.Semantic proximity Read ↗

Clinical and molecular features of progressive papillary thyroid microcarcinoma.Semantic proximity Read ↗

BRAF(V⁶⁰⁰E) mutation and its association with clinicopathological features of papillary thyroid microcarcinoma: A meta-analysis.Semantic proximity Read ↗

Molecular characterisation and clinical correlation of papillary thyroid microcarcinoma.Semantic proximity Read ↗

Papillary microcarcinoma of the thyroid: clinical characteristics and BRAF(V600E) mutational status of 977 cases.Semantic proximity Read ↗

BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study.Semantic proximity Read ↗

Thyroid Papillary Microtumor: Validation of the (Updated) Porto Proposal Assessing Sex Hormone Receptor Expression and Mutational BRAF Gene Status.Semantic proximity Read ↗

Multi-omics profiling of papillary thyroid microcarcinoma reveals different somatic mutations and a unique transcriptomic signature.Semantic proximity Read ↗

The utility of BRAF testing in the management of papillary thyroid cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.